Tuesday, September 08, 2020 8:51:05 PM
I am talking about CYD*Y. Your right their price has fallen about 50% from the high. RLFTF is down from a high of .95. So that comparison looks almost the same. Their current market cap also may reflect potential therapy in the treatment breast cancer, and HIV.
Look I am long RLTF. I am waiting on the results due anytime now. My response was to the statement in two separate posts that "all other covid stocks who lost 75%? RLFTF is the only stock holding very strong." It is not true.
Look I am long RLTF. I am waiting on the results due anytime now. My response was to the statement in two separate posts that "all other covid stocks who lost 75%? RLFTF is the only stock holding very strong." It is not true.
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
